Science Explorer Back to mapMap
Discussion
Researcher · Oregon Health & Science University · United States

Michael Charles Heinrich

Michael Charles Heinrich publishes mostly in Gastroenterology, Pulmonary and Respiratory Medicine and Hematology, on topics such as Gastrointestinal Tumor Research and Treatment, Chronic Myeloid Leukemia Treatments and Sarcoma Diagnosis and Treatment.

ORCID 0000-0003-3790-0478 OpenAlex
World rank
#28,364
of 7,710,434 ranked researchers
Rank in United States
#10,681
of 1,627,098
Works
748
Citations
53k
Citations per work
70.6
h-index
102
i10-index 292Top 0.3% in Gastroenterology
Michael Charles Heinrich

What does Michael Charles Heinrich research?

Michael Charles Heinrich's work is mostly in Medicine (64%), Biochemistry, Genetics and Molecular Biology (7%).

Health Sciences: 477 works · 63.8% of their workMedicine: 477 works · 63.8% of their workGastroenterology: 161 works · 21.5% of their workPulmonary and Respiratory Medicine: 121 works · 16.2% of their workHematology: 104 works · 13.9% of their workSurgery: 49 works · 6.6% of their workGenetics: 42 works · 5.6% of their workEverything else: 221 works · 29.6% of their workLife Sciences: 49 works · 6.6% of their workBiochemistry, Genetics and Molecular Biology: 49 works · 6.6% of their workMolecular Biology: 49 works · 6.6% of their workTHEIR WORKMichael CharlesHeinrich748works
Life Sciences7%Health Sciences64%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
    1. Medicine47763.8%
  2. Everything else22129.6%
    1. Biochemistry, Genetics and Molecular Biology496.6%
  1. 1Gastroenterology22% of their works
  2. 2Pulmonary and Respiratory Medicine16% of their works
  3. 3Hematology14% of their works
  4. 4Surgery7% of their works
  5. 5Molecular Biology7% of their works
  6. 6Genetics6% of their works

Research topics

Which keywords describe Michael Charles Heinrich's research?

The keywords of their largest research topics: Prognostic Factors, Imatinib Mesylate, Sunitinib, Chemotherapy, Clinical Practice Guidelines, BCR-ABL, Imatinib and Osteosarcoma.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.

All 19 words, with their numbers
  1. Prognostic Factors4843 topics
  2. Imatinib Mesylate3111 topic
  3. Sunitinib3111 topic
  4. Chemotherapy2062 topics
  5. Clinical Practice Guidelines2062 topics
  6. BCR-ABL1341 topic
  7. Imatinib1341 topic
  8. Osteosarcoma1111 topic
  9. Soft Tissue Sarcoma1111 topic
  10. Endoscopic Resection951 topic
  11. Gastric Cancer951 topic
  12. Intussusception791 topic
  13. Meckel's Diverticulum791 topic
  14. Chronic Lymphocytic Leukemia621 topic
  15. Genomic Aberrations621 topic
  16. Platelets421 topic
  17. Thrombosis421 topic
  18. Neurofibromatosis401 topic
  19. Tumor Suppressor401 topic

Where does Michael Charles Heinrich work?

Michael Charles Heinrich's main affiliation in the publication record is Oregon Health & Science University, United States.

How many publications and citations does Michael Charles Heinrich have?

OpenAlex counts 748 works and 52,831 citations for Michael Charles Heinrich, an h-index of 102, ranking #28,364 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Michael Charles Heinrich. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.